期刊
JOURNAL OF PSYCHIATRIC RESEARCH
卷 61, 期 -, 页码 19-24出版社
PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.jpsychires.2014.12.009
关键词
Major depression; Nitric oxide; Arginase; Platelets; Oxidative stress
类别
资金
- Conselho Nacional de Desenvolvimento Cientlfico e Tecnologico (CNPq)
- Brazilian agency of the Ministry of Science and Technology
- funding agency of the State of Rio de Janeiro (FAPERJ)
We have previously demonstrated an impairment of intraplatelet L-arginine-nitric oxide-cGMP pathway in major depression (MD) associated to platelet dysfunction. Here, we evaluated arginase pathway and phosphodiesterase 5 (PDE5) expression in platelets, systemic and intraplatelet oxidative status in untreated MD patients, and their effects on platelet aggregation. Blood samples were collected from 22 treatment naive MD patients (31 +/- 2 yr) and 27 healthy subjects (33 +/- 2 yr). MD patients presented with an activation of platelet arginase II, which competes with L-arginine for the production of nitric oxide (NO). An increase in protein carbonylation, overexpression of NADPH oxidase and PDE5, an enzyme that inactivates cGMP, was observed in platelets from MD patients compared to controls. In this context, platelet hyperaggregability was found in MD patients. On the other hand, antioxidant enzymes catalase, glutathione peroxidase and superoxide dismutase activities in serum and in platelets did not differ between groups. The increased activation of intraplatelet arginase and platelet aggregability, in addition to an overexpression of PDE5 and oxidative stress may contribute to alterations in L-arginine NO cGMP pathway and in platelet function, and consequently to the increased thrombotic risk in MD. (C) 2014 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据